Concepts (118)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Space Flight | 7 | 2022 | 158 | 2.560 |
Why?
|
| Astronauts | 3 | 2020 | 60 | 1.450 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 2020 | 21 | 0.750 |
Why?
|
| Aerospace Medicine | 2 | 2021 | 51 | 0.710 |
Why?
|
| Drug Therapy | 1 | 2020 | 205 | 0.670 |
Why?
|
| Mobile Applications | 1 | 2020 | 100 | 0.650 |
Why?
|
| Weightlessness | 4 | 2022 | 72 | 0.550 |
Why?
|
| Drug Stability | 1 | 2015 | 105 | 0.540 |
Why?
|
| Drug Storage | 1 | 2015 | 29 | 0.540 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 335 | 0.530 |
Why?
|
| Receptors, GABA-B | 2 | 2007 | 33 | 0.490 |
Why?
|
| Receptors, GABA | 3 | 2004 | 17 | 0.470 |
Why?
|
| Ion Channel Gating | 2 | 2007 | 141 | 0.460 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 521 | 0.400 |
Why?
|
| Cell Membrane Permeability | 2 | 2007 | 122 | 0.350 |
Why?
|
| Picrotoxin | 3 | 2004 | 18 | 0.340 |
Why?
|
| Receptors, Nicotinic | 2 | 2008 | 190 | 0.240 |
Why?
|
| Xenopus laevis | 5 | 2007 | 270 | 0.240 |
Why?
|
| Cholinergic Antagonists | 1 | 2004 | 58 | 0.240 |
Why?
|
| Patch-Clamp Techniques | 5 | 2007 | 388 | 0.230 |
Why?
|
| Community Pharmacy Services | 1 | 2022 | 14 | 0.210 |
Why?
|
| Pharmaceutical Services | 1 | 2022 | 34 | 0.210 |
Why?
|
| Peptide Fragments | 1 | 2004 | 1271 | 0.160 |
Why?
|
| Oocytes | 4 | 2007 | 414 | 0.160 |
Why?
|
| Membrane Potentials | 4 | 2004 | 424 | 0.160 |
Why?
|
| GABA Antagonists | 3 | 2004 | 53 | 0.150 |
Why?
|
| Pharmaceutical Preparations | 1 | 2017 | 152 | 0.130 |
Why?
|
| Nonprescription Drugs | 1 | 2015 | 52 | 0.130 |
Why?
|
| Electrophysiology | 2 | 2007 | 333 | 0.130 |
Why?
|
| Hypnotics and Sedatives | 1 | 2015 | 218 | 0.120 |
Why?
|
| Central Nervous System Stimulants | 1 | 2015 | 225 | 0.120 |
Why?
|
| Analgesics | 1 | 2015 | 390 | 0.110 |
Why?
|
| Dietary Supplements | 1 | 2015 | 558 | 0.100 |
Why?
|
| Chlorides | 2 | 2003 | 139 | 0.100 |
Why?
|
| Amino Acid Sequence | 3 | 2007 | 4233 | 0.100 |
Why?
|
| Molecular Sequence Data | 3 | 2007 | 6089 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2015 | 2803 | 0.080 |
Why?
|
| Ambystoma | 1 | 2008 | 17 | 0.080 |
Why?
|
| Acetylcholine | 1 | 2008 | 96 | 0.080 |
Why?
|
| Receptors, Cholinergic | 1 | 2008 | 84 | 0.080 |
Why?
|
| Mutation | 2 | 2007 | 15179 | 0.070 |
Why?
|
| Cohort Studies | 1 | 2020 | 9244 | 0.070 |
Why?
|
| Humans | 10 | 2022 | 261506 | 0.070 |
Why?
|
| Glutamic Acid | 1 | 2007 | 309 | 0.070 |
Why?
|
| Time Factors | 1 | 2020 | 12926 | 0.070 |
Why?
|
| Cholinergic Agonists | 1 | 2004 | 9 | 0.060 |
Why?
|
| Carbachol | 1 | 2004 | 28 | 0.060 |
Why?
|
| Ethyl Methanesulfonate | 1 | 2004 | 8 | 0.060 |
Why?
|
| Retina | 1 | 2008 | 532 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2007 | 850 | 0.060 |
Why?
|
| Nitric Oxide | 1 | 2008 | 644 | 0.060 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2004 | 289 | 0.060 |
Why?
|
| Female | 6 | 2020 | 141928 | 0.060 |
Why?
|
| Cell Line | 2 | 2003 | 5114 | 0.060 |
Why?
|
| Neurons | 2 | 2008 | 2287 | 0.060 |
Why?
|
| Animals | 8 | 2017 | 59536 | 0.060 |
Why?
|
| Microinjections | 1 | 2003 | 96 | 0.060 |
Why?
|
| Risk Factors | 1 | 2020 | 17523 | 0.060 |
Why?
|
| Drug Interactions | 1 | 2004 | 553 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2004 | 844 | 0.050 |
Why?
|
| Bed Rest | 1 | 2022 | 23 | 0.050 |
Why?
|
| Transfection | 2 | 2004 | 2944 | 0.050 |
Why?
|
| Ion Channels | 1 | 2003 | 212 | 0.050 |
Why?
|
| In Vitro Techniques | 1 | 2004 | 1618 | 0.050 |
Why?
|
| Adult | 2 | 2020 | 77950 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2003 | 869 | 0.050 |
Why?
|
| Pharmacists | 1 | 2022 | 95 | 0.050 |
Why?
|
| Professional Role | 1 | 2022 | 78 | 0.050 |
Why?
|
| Anions | 1 | 1999 | 39 | 0.050 |
Why?
|
| Adaptation, Physiological | 1 | 2022 | 360 | 0.050 |
Why?
|
| Cations | 1 | 1999 | 62 | 0.050 |
Why?
|
| Electric Conductivity | 1 | 1999 | 94 | 0.050 |
Why?
|
| Kinetics | 1 | 2003 | 2049 | 0.040 |
Why?
|
| Receptors, GABA-A | 1 | 1999 | 79 | 0.040 |
Why?
|
| Receptors, Glycine | 1 | 1998 | 22 | 0.040 |
Why?
|
| Chloride Channels | 1 | 1998 | 60 | 0.040 |
Why?
|
| Models, Biological | 1 | 2007 | 3254 | 0.040 |
Why?
|
| Pharmacokinetics | 1 | 2017 | 42 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2020 | 37905 | 0.040 |
Why?
|
| Calcium | 1 | 2003 | 1537 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 4938 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2022 | 918 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 3154 | 0.030 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2008 | 269 | 0.030 |
Why?
|
| Middle Aged | 1 | 2020 | 86204 | 0.030 |
Why?
|
| Liver | 1 | 2003 | 2961 | 0.030 |
Why?
|
| Hippocampus | 1 | 1998 | 915 | 0.030 |
Why?
|
| Algorithms | 1 | 2003 | 3890 | 0.030 |
Why?
|
| Gene Expression | 1 | 1999 | 3570 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 1998 | 1491 | 0.020 |
Why?
|
| Kidney | 1 | 1999 | 2146 | 0.020 |
Why?
|
| Amacrine Cells | 1 | 2008 | 35 | 0.020 |
Why?
|
| Receptors, Muscarinic | 1 | 2008 | 69 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 2008 | 116 | 0.020 |
Why?
|
| Visual Pathways | 1 | 2008 | 86 | 0.020 |
Why?
|
| Neural Inhibition | 1 | 2008 | 147 | 0.020 |
Why?
|
| Nitric Oxide Synthase | 1 | 2008 | 314 | 0.020 |
Why?
|
| Vision, Ocular | 1 | 2008 | 157 | 0.020 |
Why?
|
| Glycine | 1 | 2008 | 289 | 0.020 |
Why?
|
| Male | 1 | 2015 | 123000 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 2008 | 443 | 0.020 |
Why?
|
| Cadmium | 1 | 2004 | 57 | 0.020 |
Why?
|
| Cysteine | 1 | 2004 | 214 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2004 | 611 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 644 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 3639 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 1879 | 0.010 |
Why?
|
| Binding Sites | 1 | 2004 | 2171 | 0.010 |
Why?
|
| Sesterterpenes | 1 | 1998 | 1 | 0.010 |
Why?
|
| Ionophores | 1 | 1998 | 22 | 0.010 |
Why?
|
| Ion Transport | 1 | 1998 | 79 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 2927 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 3203 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 7548 | 0.010 |
Why?
|
| Action Potentials | 1 | 1998 | 560 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1998 | 2063 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2008 | 11965 | 0.010 |
Why?
|
| Rats | 1 | 1998 | 6086 | 0.010 |
Why?
|